Investigating how cation-chloride cotransporters affect brain and kidney function
Structures and Pharmacology of Cation-Chloride Cotransporters
This study is looking at how certain proteins in our cells help control the movement of important minerals, which can help us find new ways to treat brain conditions like epilepsy and manage blood pressure in the kidneys, so that patients can feel better and have healthier lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10903734 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of cation-chloride cotransporters (CCCs) in regulating ion movement across cell membranes, which is crucial for maintaining cell volume and neuronal excitability. By studying the pharmacological modulation of these transporters, the research aims to develop new therapeutic strategies for treating brain disorders such as epilepsy and for managing blood pressure in kidney function. The approach includes examining the molecular mechanisms of CCCs and their regulation by various kinases in response to hormonal signals and cellular changes. Patients may benefit from insights gained into how these transporters can be targeted to restore balance in neuronal signaling and electrolyte levels.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with epilepsy, brain disorders, or conditions related to electrolyte imbalance and hypertension.
Not a fit: Patients with non-neurological conditions or those not affected by electrolyte imbalances may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for epilepsy and other brain disorders, as well as improved management of blood pressure.
How similar studies have performed: Previous research has shown promising results in targeting similar transport mechanisms for therapeutic purposes, indicating potential for success in this area.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Cao, Erhu — University of Utah
- Study coordinator: Cao, Erhu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.